Recent Posts

Blog, Patient Advocacy, RareDiseases, Schinzel-Giedion Syndrome, Chapter 1
How Schinzel-Giedion Syndrome (SGS) has changed our lives
Posted 28th May 2021

How Schinzel-Giedion Syndrome (SGS) has changed our lives

Read More
Blog , Patient Advocacy , epilepsy , RareDiseases , Chapter 8
Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust
Posted 21st May 2021

Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust

Read More
Blog , Patient Advocacy , Champ1 , RareDiseases
Our CHAMP1 journey
Posted 14th May 2021

Our CHAMP1 journey

Read More
previous
1 2 3
Blog , Patient Advocacy , RareDiseases , Schinzel-Giedion Syndrome , Chapter 1
How Schinzel-Giedion Syndrome (SGS) has changed our lives
Posted 28th May 2021

How Schinzel-Giedion Syndrome (SGS) has changed our lives

Read More
Blog , Patient Advocacy , epilepsy , RareDiseases , Chapter 8
Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust
Posted May May 21st 2021

Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust

Read More
Blog , Patient Advocacy , Champ1 , RareDiseases
Our CHAMP1 journey
Posted May May 14th 2021

Our CHAMP1 journey

Read More
previous
1 2 3
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2021 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.